Delivery Order SPE2DB22D2006-SPE2DB24FV8QW
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Zoloft 50 mg tablets. The $3,755.16 award has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued against an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,721.59 contract is to provide ZOLOFT 50 MG TABLET 30S, a prescription medication, to support military treatment programs. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a delivery order valued at $3,657.27 to AmerisourceBergen Drug Corp for the supply of Zoloft 100 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- This is a delivery order under a contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,295.76, is for the delivery of the generic medication Zoloft 50 mg tablets. This contract is not designated as a set-aside and is awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc....
- Amerisourcebergen Drug Corp has received a $5,142 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 30 tablets of the generic antidepressant Zoloft (sertraline hydrochloride) 100 mg. As a prime contractor, Amerisourcebergen provides pharmaceutical products and medical supplies in support of DLA programs from its Corporate Office division located in Conshohocken, Pennsylvania. Amerisourcebergen holds an indefinite delivery contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,467.77 to AmerisourceBergen Drug Corp for the supply of Zoloft 100 mg tablets (30-count packaging) under a firm fixed-price contract type. The award was made on December 30, 2025, with an ultimate completion date of December 31, 2025, and represents a non-set-aside competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Zoloft 100 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $24,072.27 and a period of performance through March 21, 2022. No set-aside designation was used for this award....
- The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,858,477 units of the drug ZOLOFT 100 MG TABLET 30S. The $16,821.28 delivery order does not have a set-aside designation and was completed on April 12, 2022. Amerisourcebergen Drug Corp is an experienced federal contractor that has received numerous awards from DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,197.87, is for the provision of Zoloft 100 mg tablets. The contract has a firm fixed price pricing type and a period of performance through November 21, 2023. This appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zoloft 50 mg tablets, a medication used to treat mental health conditions. The contract has a firm fixed price of $7,242.16 and an ultimate completion date of November 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8QWDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Zoloft 50 mg tablets in 30-count packages, with a firm fixed price of $3,823.66 and a performance period through March 8, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract was awarded to their Corporate Office division located in Conshohocken, Pennsylvania. The contract supports the DLA Troop Support Medical program, which provides pharmaceuticals and medical supplies to U.S. military treatment facilities worldwide. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division for medical supplies and prescription medications, as well as a single-award indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2025 for a comprehensive range of pharmaceutical products and medical materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 3/7/24 |